EC
PFE icon

Enhancing Capital’s Pfizer PFE Stock Holding History

Enhancing Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-41,600
Closed -$1.01M – 92
2025
Q2 		$1.01M Hold
41,600
– – 0.77% 39
2025
Q1 		$1.05M Hold
41,600
– – 0.84% 37
2024
Q4 		$1.1M Buy
+41,600
New +$1.13M 0.88% 34
2022
Q3 		$1.76M Hold
41,600
– – 2.18% 13
2022
Q2 		$2.18M Hold
41,600
– – 2.6% 9
2022
Q1 		$2.15M Hold
41,600
– – 2.3% 12
2021
Q4 		$2.46M Buy
+41,600
New +$2.06M 2.67% 8

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Enhancing Capital's PFE Position: Q3 2025 in Review

Enhancing Capital sold out of Pfizer (PFE) in Q3 2025, closing a stake of 41,600 shares — an estimated $1.01M sold.

Enhancing Capital first reported a position in PFE in Q4 2021 and held it in 7 quarters. The position peaked at $2.46M in Q4 2021. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • Enhancing Capital reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
  • Enhancing Capital sold 41,600 Pfizer shares in Q3 2025, an estimated $1.01M.
  • Enhancing Capital first reported a position in Pfizer in Q4 2021 and held it in 7 quarters.
  • Enhancing Capital's Pfizer position peaked at $2.46M in Q4 2021.
  • 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Enhancing Capital's 13F filing for Q3 2025, filed 13 Nov 2025.